Interaction among nitric oxide (NO)-related genes in migraine susceptibility

Molecular and Cellular Biochemistry

Volumn 370, Issue 1-2, 2012, Pages 183-189

  Gonçalves, Flavia M ^a   Luizon, Marcelo R ^b   Speciali, Jose G ^b   Martins Oliveira, Alisson ^b   Dach, Fabiola ^b   Tanus Santos, Jose E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelial nitric oxide synthase; Epistasis; Inducible nitric oxide synthase; Migraine; Polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DEMOGRAPHY; EPISTASIS, GENETIC; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MIGRAINE DISORDERS; MODELS, GENETIC; MULTIFACTOR DIMENSIONALITY REDUCTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867332004     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1409-5     Document Type: Article

References (43)

1. Maher BH, Griffiths LR (2011) Identification of molecular genetic factors that influence migraine. Mol Genet Genomics 285:433-446
2. Victor T, Hu X, Campbell J, Buse D, Lipton R (2010) Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 30:1065-1072
3. Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7:354-361
4. Martins-Oliveira A, Speciali JG, Dach F, Marcaccini AM, Gonçalves FM, Gerlach RF, Tanus-Santos JE (2009) Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408:60-64
5. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327-341
6. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74:628-635
7. Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11:92-100
8. Schurks M, Buring JE, Ridker PM, Chasman DI, Kurth T (2011) Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS ONE 6:e22106
9. Olesen J (2010) Nitric oxide-related drug targets in headache. Neurotherapeutics 7:183-190
10. Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P (2009) Pathophysiological basis of migraine prophylaxis. Prog Neurobiol 89:176-192
11. Pietrobon D, Striessnig J (2003) Neurological diseases: neurobiology of migraine. Nat Rev Neurosci 4:386-398
12. Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157-171
13. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, Pini LA, Calabresi P (2006) NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia 26:1071-1079
14. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, Theoharides TC, Waeber C, Moskowitz MA (2001) Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124:2490-2502
15. Reuter U, Chiarugi A, Bolay H, Moskowitz MA (2002) Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 51:507-516
16. Scharfman HE, MacLusky NJ (2008) Estrogen growth factor interactions and their contributions to neurological disorders. headache. J Head Face Pain 48:S77-S89
17. Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM (2009) Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54:652-658
18. Goncalves FM, Martins-Oliveira A, Speciali JG, Izidoro-Toledo TC, Luizon MR, Dach F, Tanus-Santos JE (2010) Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA Cell Biol 29:357-362
19. Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, Dach F, Tanus-Santos JE (2011) Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol 30:363-369
20. MacClellan LR, Howard TD, Cole JW, Stine OC, Giles WH, O'Connell JR, Wozniak MA, Stern BJ, Mitchell BD, Kittner SJ (2009) Relation of candidate genes that encode for endothelial function to migraine and stroke: the stroke prevention in young women study. Stroke 40:e550-e557
21. Mansur OS, Gonçalves FM T, Martins-Oliveira A, Speciali JG, Speciali JG, Dach F, Lacchini R, Tanus-Santos JE (2012) Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem 364:303-308
22. Crawford DC, Nickerson DA (2005) Definition and clinical importance of haplotypes. Annu Rev Med 56:303-320
23. Goncalves FM, Luizon MR, Speciali JG (2012) Haplotypes in candidate genes related to nitric oxide pathway and vascular permeability associated with migraine and aura. J Headache Pain 13:335-336
24. Schürks M (2011) Genetics of migraine in the age of genome-wide association studies. J Headache Pain 13:1-9
25. Schürks M, Kurth T, Buring JE, Zee RYL (2009) A candidate gene association study of 77 polymorphisms in migraine. J Pain 10:759-766
26. Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56:73-82
27. Moore JH (2004) Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 4:795-803
28. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147
29. Motsinger AA, Brassat D, Caillier SJ, Erlich HA, Walker K, Steiner LL, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD (2007) Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics 8:11-20
30. Corominas R, Sobrido MJ, Ribasés M, Cuenca-León E, Blanco-Arias P, Narberhaus B, Roig M, Leira R, López-González J, Macaya A, Cormand B (2009) Association study of the serotoninergic system in migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet 153:177-184
31. Joshi G, Pradhan S, Mittal B (2010) Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C→G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia 30:311-320
32. Joshi G, Pradhan S, Mittal B (2011) Vascular gene polymorphisms (EDNRA -231 G>A andAPOEHhaI) and risk for migraine. DNA Cell Biol 30:577-584
33. Lemos C, Mendonca D, Pereira-Monteiro J, Barros J, Sequeiros J, Alonso I, Sousa A (2010) BDNF and CGRP interaction: implications in migraine susceptibility. Cephalalgia 30:1375-1382
34. Oterino A, Toriello M, Cayón A, Castillo J, Colas R, Alonson-Arranz A, Ruiz-Alegria C, Quintela E, Monton F, Ruiz-Lavilla N, Gonzalez F, Pascual J (2008) Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine. headache. J Head Face Pain 48:1438-1450
35. Schürks M, Zee RYL, Buring JE, Kurth T (2009) Polymorphisms in the renin-angiotensin system and migraine in women. headache. J Head Face Pain 49:292-299
36. SotIH Society HC (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
37. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15:115-120
38. Luizon MR, Izidoro-Toledo TC, Simoes AL, Tanus-Santos JE (2009) Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 28:329-334
39. Pattin KA, White BC, Barney N, Gui J, Nelson HH, Kelsey KT, Andrew AS, Karagas MR, Moore JH (2009) A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol 33:87-94
40. Wang SS (2006) Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27:1828-1834
41. Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149-153
42. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J (1997) Nitric oxide synthase inhibition in migraine. Lancet 349:401-402
43. Hoffmann J, Goadsby PJ (2011) New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 14:50-59